The Effects of Serum Vitamin D and IVF Outcome

The purpose of this study is to investigate whether an association exists between serum vitamin D levels and IVF treatment outcome

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vitamin D Deficiency Avitaminosis Deficiency Diseases Genital Diseases Infertility Malnutrition Nutrition Disorders Nutritional and Metabolic Diseases Urogenital Diseases Vitamin D Insufficiency

Age range

23 year–43 year

Sex eligibility

Female

Study type

Observational

Primary location

Birmingham Womens NHS Foundation Trust

Birmingham, West Midlands, B15 2TG, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients undergoing IVF, ICSI or FET treatment at Birmingham Womens Fertility Centre

Exclusion criteria

None

Treatment and study plan

Primary outcomes

Clinical Pregnancy Rate

Time frame: 7 weeks after embryo transfer

USS appearances of intrauterine pregnancy

Secondary outcomes

Biochemical pregnancy rate

Time frame: 2 weeks after embryo transfer

Urinary pregnancy test result 2 weeks after embryo transfer
Miscarriage rate

Time frame: 20 weeks after embryo transfer

Pregnancy outcome of miscarriage
Live birth rate

Time frame: 42 weeks after embryo transfer

Live birth outcome

Sponsors and collaborators

Lead sponsor

University of Birmingham

Other

Registry information

Official study title

The Effects of Serum Vitamin D and IVF Outcome: a Prospective Cohort Study

Acronym: VIDIO

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2015
First posted: Jul 10, 2014
Registry last updated: Oct 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed